Biotech

All Articles

A better consider Tough Biotech's Brutal 15

.Within this full week's episode of "The Leading Pipe," our team are actually diving into Intense Bi...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's event commemorating the approval of ...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of notable management hirings, shootings and...

Lykos are going to inquire FDA to reconsider its choice observing denial of MDMA therapy for post-traumatic stress disorder

.Complying with a bad revealing for Lykos Rehabs' MDMA candidate for trauma at a current FDA advisin...

AN 2 one-halfs headcount, ceases period 3 test after data disappoint

.AN2 Therapeutics is actually rethinking its service in response to lackluster midphase records, pro...

Merck pays $700M for bispecific, snooping autoimmune position and also opportunity to challenge Amgen in cancer

.Merck &amp Co. is paying out $700 thousand beforehand to test Amgen in a blood stream cancer market...

Gilead spends J&ampJ $320M to leave licensing package for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver health condition drug seladelpar, t...

' All palms on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can view the companies putting together camping tents at baseca...

Entero laying off team, vacating workplace and stopping R&ampD

.Bed Liquidators has transformed Entero Therapeutics white colored as a sheet. The financial institu...

Exelixis falls ADC after determining it is actually no match for Tivdak

.Exelixis is actually losing hope on its own tissue variable (TF)- targeting antibody-drug conjugate...